Using low dose aspirin to prevent recurrent preterm birth
Official title: A Dose Escalation Study of Low Dose Aspirin for the Prevention of Recurrent Preterm Birth
Funded at George Washington University · NIH-11111265 · Data updated 2026-11-12
This study is looking at how low doses of aspirin might help women who are at risk of having another preterm baby, by finding the best dose to prevent issues like preeclampsia and slow growth in the baby.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | George Washington University NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project start | June 10, 2024 |
| Project end | March 31, 2029 |
| Funding year | 2025 |
| Award (this year) | $2,789,344 |
| NIH project number | 5U01HD109332-02 |
| Project ID | NIH-11111265 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are women who have a history of preterm birth and are currently pregnant or planning to become pregnant.
✕Less likely to help
Patients who have not experienced preterm birth or those with contraindications to aspirin use may not benefit from this research.
What this research studies
This research investigates the effectiveness of low dose aspirin in preventing recurrent preterm births among at-risk women. The study will involve a dose escalation approach, where different doses of aspirin will be tested to determine the optimal amount for preventing complications associated with preterm birth, such as preeclampsia and fetal growth restriction. Participants will be monitored closely throughout their pregnancy to assess the impact of the treatment on birth outcomes. The goal is to provide a safe and effective preventive strategy for women who have experienced preterm births in the past.
Why it matters
Potential benefit: If successful, this research could significantly reduce the rates of recurrent preterm births and improve outcomes for both mothers and their babies.
How similar studies have gone: Previous studies have shown promising results with low dose aspirin in reducing preterm birth rates, indicating that this approach has potential based on earlier findings.
Where this research is happening
-
George Washington University
Washington, United States Active
Researchers
- Principal investigator: Clifton, Rebecca Gersnoviez — George Washington University
- Study coordinator: Clifton, Rebecca Gersnoviez
Related research
Other NIH-funded projects on the same topics.
-
Screening and treatment of Chlamydia infection in pregnancy to help prevent preterm birth
This grant studies whether screening pregnant people for Chlamydia trachomatis and treating those who are positive can reduce the risk of preterm birth.
-
Xylitol to Prevent Periodontal Disease and Preterm Birth in Pregnancy and Early Childhood
A safe, inexpensive chewable gum approach using xylitol is tested to help pregnant people reduce gum disease and lower the chance of preterm birth and related child health problems.
-
Screening and treatment for Chlamydia infection to help prevent preterm birth
A study in pregnant people will test whether screening for Chlamydia trachomatis and treating it during pregnancy can reduce the risk of babies being born too early.
-
IL-9 Signaling and Immune-Driven Preterm Birth
This NIH grant supports training a physician-scientist to lead a new lab studying how immune signals, especially IL-9, affect preterm birth.
-
Predicting Preterm Birth with Longitudinal Multi-Omics Data
A new, patient-friendly approach uses time-aware omics data from pregnancy to better predict preterm birth and uncover underlying biology.
-
Skeletal health after preterm birth in adults
Researchers will study why people born prematurely have weaker bones and fractures, starting in infancy and following into adulthood.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.